Fresenius SE & Co. KGaA is a health care company based in Bad Homburg vor der Höhe, Germany. The company provides products and services for dialysis, hospitals as well as inpatient and outpatient medical care. The company also focuses on hospital management as well as on engineering and services for medical centers and other health care facilities.
Fresenius Helios is the largest hospital operator and provider of inpatient and outpatient in Germany. The Helios Kliniken has more than 110 hospitals and more than 30,000 beds, treating over 4 million patients annually.
In 1946, Fresenius died. Else Kröner, his foster-daughter and protegée, who was still in pharmacy school at the time, inherited the company. Else Kröner rescued the company from significant debts by laying off the majority of staff and restructuring the business. Kröner died in 1988. Kröner's will left all of her assets to the Else Kröner-Fresenius-Foundation, which funds medical research.
In 1966, the company began to sell dialysis machines.
In November 2014, the company announced that its Russian partners, Sistema and Zenitco Finance Management, agreed to terminate their joint venture agreement that had been established in April 2014. The termination was prompted by changing political and regulatory circumstances in the region.
In January 2016, Fresenius Kabi announced that it would acquire Becton Dickinson's prescription drug business.
In January 2017, Fresenius acquired the largest Spanish hospital group, the Grupo Hospitalario Quirónsalud for €5.76 billion and merged it into the Helios Group, establishing the biggest hospital group of Europe.
Concerns of use of hydroxyethyl starch and threats against researcher
In 2012, a paper was published raising concerns regarding the use of hydroxyethyl starch in sepsis. Fresenius Kabi, which makes the product, threatened legal action against the main author, Danish scientist Anders Perner.
^Perner, Anders; Haase, Nicolai; Guttormsen, Anne B.; Tenhunen, Jyrki; Klemenzson, Gudmundur; Åneman, Anders; Madsen, Kristian R.; Møller, Morten H.; Elkjær, Jeanie M.; Poulsen, Lone M.; Bendtsen, Asger; Winding, Robert (July 12, 2012). "Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis". The New England Journal of Medicine. 367 (2): 124–34. doi:10.1056/NEJMoa1204242. PMID22738085.